Skip to content

Yohimbine

Yohimbe is a tree bark native to West Africa. The psychoactive ingredient yohimbine contained in it has a strong aphrodisiac effect on both sexes from 8 mg. Male consumers experience an increase in potency. This eroticizing effect is much stronger with a tea made from the yohimbe bark, boiled with all the psychoactive ingredients, than with the pure substance yohimbine. Yohimbine promotes blood circulation in the groin area and is a blood pressure-lowering agent.

Which plant does yohimbine bark come from?

It is primarily the dark brown bark (cortex yohimbe) of the Pausinystalia yohimbe tree, which is native to tropical West Africa. The bark of other Pausinystalia species and that of smaller trees, the botanically closely related Corynanthe species, is also used as a substitute or adulteration for the "real" yohimbe bark.

How does yohimbine work?

It is considered an alpha-adrenoceptor blocker and sympatholytic. As a result, it has a vasodilating effect and low-dose antihypertensive, high-dose antihypertensive, mild diuretic and pupil-dilating effect. It can also act as an aphrodisiac, especially in men, by dilating the blood vessels of the sexual organs and increasing the excitability of the spinal cord centers responsible for sexual function without necessarily increasing sexual desire, as the medical literature so nicely puts it. However, this effect should only occur with regular use or higher doses and only in some users. Users of higher doses have reported slight changes in consciousness, especially in sensory perception, in the direction of "psychedelic". Some also experience a kind of drowsiness. Unpleasant effects can also occur, especially at higher doses. The ability to react can be significantly impaired, which calls for appropriate restraint during activities that require it. Muscle tremors and nervous agitation are considered annoying side effects. Increased anxiety and slightly aggressive irritability do not appear to be uncommon. Slight nausea, headaches, increased sweating and reddening of the skin may occur. Excessive doses can lead to urinary retention, diarrhea, vomiting, central excitement, coordination disorders, severe shakiness, a "disturbed" state, possibly with anxiety or even "hallucinations", epileptic convulsions, a decrease in the oxygen content in the blood with blue coloration of the skin, a sharp increase in the heart rate, an increase in blood pressure (!) and unconsciousness. Painful permanent erections have also been reported. Extremely high doses of yohimbine can lead to death. It is advisable to seek medical help in the event of a severe overdose. But it doesn't have to come to that.

Need in sport

Yohimbine can be described without exaggeration as a multifunctional active ingredient. For athletes interested in improving their performance, especially bodybuilders, yohimbine is interesting in other respects. Yohimbine is well suited for fat loss. Blocking the alpha2 receptors leads to an increased release of noradrenaline in the body and thus to a slight increase in body temperature (thermogenesis), increased metabolic activity and a slightly reduced appetite. In addition, the receptors are also blocked in fatty tissue, where they act as inhibitors of fat burning. Thus, the use of yohimbine also leads to increased fat burning in this way. It works well for this purpose and offers a decisive advantage over the well-known ephedrine/caffeine combination, as it is particularly effective in stubborn problem areas. Women in particular benefit from this effect, as they have a particularly high number of alpha2 receptors in those fat deposits that are difficult to break down even with a diet, the so-called >>stubborn<< areas such as the stomach, bottom and thighs. The circulation-promoting effect of yohimbine also contributes to increased fat loss throughout the body, which not only affects the genital area, but also fatty tissue with comparatively poor circulation. However, it must be emphasized that yohimbine only promotes fat loss in conjunction with a calorie-reduced diet. Bodybuilders and athletes often use yohimbine in the last 4-6 weeks before a competition in order to match the lower body hardness and definition to the usually better trained upper body. My recommendation, if you want to reduce excess body fat, is a dosage of 10mg three times a day or 500-600mg Yohimbe Bark Extract (standardized to 2% Yohimbe). Ideally, the tablets should be taken approximately one hour before a meal. It is not recommended to take the tablets with meals, as insulin negates the effect of yohimbine on the A2 receptors. The intake should initially be started with a low dose, which is increased to the recommended amount over the course of 1-2 weeks. In this way, the numerous side effects can be avoided as the body slowly becomes accustomed to the substance. If you want to add the active ingredient to an ephedrine/caffeine/white willow stack, you will find a damn strong alternative means of fat loss without steroids.

References

  1. Kucio C, Jonderko K, Piskorska D. Does yohimbine act as a slimming drug? Isr J Med Sci. 1991 Oct;27(10):550-6
  2. Berlan M, Galitzky J, Riviere D, Foureau M, Tran MA, Flores R, Louvet JP, Houin G, Lafontan M. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes. 1991 May;15(5):305-15
  3. Galitzky J, Taouis M, Berlan M, Riviere D, Garrigues M, Lafontan M. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. 1988 Dec;18(6):587-94
  4. Galitzky J, Riviere D, Tran MA, Montastruc JL, Berlan M. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers. Eur J Clin Pharmacol. 1990;39(5):447-51
  5. Currie PJ, Wilson LM. Yohimbine attenuates clonidine-induced feeding and macronutrient selection in genetically obese (ob/ob) mice. Pharmacol Biochem Behav. 1992 Dec;43(4):1039-46
  6. Arner P, Kriegholm E, Engfeldt P, Bolinder J. Adrenergic regulation of lipolysis in situ at rest and during exercise. J Clin Invest. 1990 Mar;85(3):893-8
  7. Millet L, Barbe P, Lafontan M, Berlan M, Galitzky J. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J Appl Physiol. 1998 Jul;85(1):181-8
  8. Galitzky J, Lafontan M, Nordenstrom J, Arner P. Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue. J Clin Invest. 1993 May;91(5):1997-2003.
  9. Carro-Juareza M, Rodriguez-Manzo G. Yohimbine reverses the exhaustion of the coital reflex in spinal male rats. Behav Brain Res. 2003 Apr 17;141(1):43-50
  10. Rodriguez-Manzo G, Fernandez-Guasti A. Participation of the central noradrenergic system in the reestablishment of copulatory behavior of sexually exhausted rats by yohimbine, naloxone, and 8-OH-DPAT. Brain Res Bull. 1995;38(4):399-404
  11. Tam SW, Worcel M, Wyllie M. Yohimbine: a clinical review. Pharmacol Ther. 2001 Sep;91(3):215-43
  12. Meston CM, Worcel M. The effects of yohimbine plus L-arginine glutamate on sexual arousal in postmenopausal women with sexual arousal disorder. Arch Sex Behav. 2002 Aug;31(4):323-32
  13. Guay AT, Spark RF, Jacobson J, Murray FT, Geisser ME. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial. Int J Impot Res. 2002 Feb;14(1):25-31
  14. Southwick SM, Morgan CA 3rd, Charney DS, High JR. Yohimbine use in a natural setting: effects on posttraumatic stress disorder. Biol Psychiatry. 1999 Aug 1;46(3):442-4
  15. Cameron OG, Zubieta JK, Grunhaus L, Minoshima S. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosom Med. 2000 Jul-Aug;62(4):549-59
  16. Betz JM, White KD, der Marderosian AH. Gas chromatographic determination of yohimbine in commercial yohimbe products. J AOAC Int. 1995 Sep-Oct;78(5):1189-94
  17. Greenway FL, Bray GA, Heber D. Topical fat reduction. Obes Res. 1995 Nov;3 Suppl 4:561S-568S
  18. Le Corre P, Dollo G, Chevanne F, Le Verge R. Biopharmaceutics and metabolism of yohimbine in humans. Eur J Pharm Sci. 1999 Oct;9(1):79-84
  19. Gomez-Ambrosi J, Fruhbeck G, Aguado M, Milagro FI, Margareto J, Martinez AJ. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats. Int J Mol Med. 2001 Jul;8(1):103-9
  20. Waluga M, Janusz M, Karpel E, Hartleb M, Nowak A. Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women. Clin Physiol. 1998 Jan;18(1):69-76
  21. Arndt K. (HG.) (2001) Handbuch Nahrungsergänzungen-Bedeutung und Anwendung leistungssteigernder Substanzen für Bodybuilding und Kraftsport. Pages: 124-128